Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil

被引:1
|
作者
Pacheco, Vanessa [1 ]
Guimaraes, Rosane Cuber [2 ]
Correa-Moreira, Danielly [3 ]
Magalhaes, Carlos Eduardo [4 ]
Figueiredo, Douglas [4 ]
Guttmann, Patricia [5 ]
Trindade, Gisela Freitas [6 ]
da Silva, Juliana Fernandes Amorim [6 ]
Bom, Ana Paula Dinis Ano [7 ]
Maia, Maria de Lourdes [8 ]
Melgaco, Juliana Gil [7 ]
Barros, Tamiris Azamor da Costa [7 ]
da Silva, Andrea Marques Vieira [7 ]
Oliveira, Manoel Marques Evangelista [3 ]
机构
[1] Biomanguinhos Fiocruz, Qual Assurance Dept, BR-21040900 Rio De Janeiro, Brazil
[2] Biomanguinhos Fiocruz, BR-21040900 Rio De Janeiro, Brazil
[3] Oswaldo Cruz Inst Fiocruz, Lab Taxon Biochem & Bioprospecting Fungi, BR-21041250 Rio De Janeiro, Brazil
[4] UERJ Universitary Hosp Pedro Ernesto, Outpatient Vasc Surg, BR-20950003 Rio De Janeiro, Brazil
[5] Municial Hlth Secretary Rio de Janeiro, BR-20211110 Rio De Janeiro, Brazil
[6] Bio manguinhos Fiocruz, Lab Virol Tecnol, BR-21040900 Rio De Janeiro, Brazil
[7] Bio manguinhos Fiocruz, Lab Imunol Tecnol, BR-21040900 Rio De Janeiro, Brazil
[8] Bio manguinhos Fiocruz, Clin Assessory, BR-21040900 Rio De Janeiro, Brazil
来源
VIRUSES-BASEL | 2023年 / 15卷 / 07期
关键词
SARS-CoV-2; COVID-19; immune response; cytokine storm; acute infection; COVID-19;
D O I
10.3390/v15071609
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1 & beta;, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cytokine profile in patients with osteoarthritis after SARS-CoV-2 infection
    Krenytska, Daryna
    Kot, Larysa
    Halenova, Tetiana
    Raksha, Nataliia
    Vovk, Tetiana
    Savchuk, Olexii
    Pellicano, Rinaldo
    Abenavoli, Ludovico
    Falalyeyeva, Tetyana
    Ostapchenko, Liudmyla
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2022, 34 (04): : 196 - 203
  • [42] Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
    Afridonova, Zulfiia E.
    Toptygina, Anna P.
    Mikhaylov, Ilya S.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (05) : 872 - 882
  • [43] Olfactory immune response to SARS-CoV-2
    Wellford, Sebastian A.
    Moseman, E. Ashley
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (02) : 134 - 143
  • [44] IMMUNE RESPONSE TO SARS-COV-2 INFECTION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES: THE MAINSTREAM STUDY
    Favalli, E. G.
    Favalli, A.
    Andrea, G.
    Maioli, G.
    Zagato, E.
    Bombaci, M.
    Pesce, E.
    Donnici, L.
    Gruarin, P.
    Biggioggero, M.
    Curti, S.
    Manganaro, L.
    Marchisio, E.
    Bevilacqua, V.
    Martinovic, M.
    Fabbris, T.
    Sarnicola, M. L.
    Crosti, M.
    Marongiu, L.
    Granucci, F.
    Notabartolo, S.
    Bandera, A.
    Gori, A.
    De Francesco, R.
    Abrignani, S.
    Caporali, R.
    Grifantini, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 367 - 368
  • [45] Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy
    Wang, Meixi
    Zhao, Yuanyuan
    Wei, Lai
    Chen, Dong
    Yang, Bo
    Chen, Zhishui
    CRITICAL REVIEWS IN IMMUNOLOGY, 2020, 40 (06) : 475 - 484
  • [46] Olfactory immune response to SARS-CoV-2
    Sebastian A. Wellford
    E. Ashley Moseman
    Cellular & Molecular Immunology, 2024, 21 : 134 - 143
  • [47] Clinical and humoral immune response characterization of SARS-CoV-2 Omicron BA.2.38 infection in pediatric patients
    Liu, Yu
    Zhao, Liunuobei
    Wang, Li
    Li, Yuxia
    Wang, Longde
    Yu, Bo
    Hu, Di
    Weng, Heng
    Guo, Jianwen
    Yang, Jinghua
    Yang, Jing
    Yu, Xiaobo
    HELIYON, 2023, 9 (07)
  • [48] Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome
    Boelke, Edwin
    van Griensven, Martijn
    Schneider, E. Marion
    Fischer, Johannes C.
    Feldt, Torsten
    Keitel, Verena
    Budach, Wilfried
    Haussmann, Jan
    Jazmati, Danny
    Matuschek, Christiane
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Immune Response to SARS-CoV-2 Vaccines
    Bellamkonda, Navya
    Lambe, Upendra Pradeep
    Sawant, Sonali
    Nandi, Shyam Sundar
    Chakraborty, Chiranjib
    Shukla, Deepak
    BIOMEDICINES, 2022, 10 (07)
  • [50] Immune Profile of SARS-CoV-2 Variants of Concern
    La Porta, Caterina A. M.
    Zapperi, Stefano
    FRONTIERS IN DIGITAL HEALTH, 2021, 3